Actively Recruiting

Phase Not Applicable
Age: 0 - 3Days
All Genders
Healthy Volunteers
NCT05813730

Urinary Creatinine Excretion Time in the Neonatal Period

Led by Central Hospital, Nancy, France · Updated on 2025-02-19

40

Participants Needed

1

Research Sites

56 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Newborn's renal function is difficult to assess and its physiology during the first days of life is still incompletely known. Studies suggest that the newborn almost completely reabsorbs creatinine during the first 48 to 72 hours of life, while at the same time it continues to produce its own creatinine. Therefore, the initial stock of creatinine at birth still increases through this production and the non or weak clearance. A better knowledge of renal physiopathology in newborns would allow to improve the therapeutic management of the infants, particularly in case of potential nephrotoxicity. No study has attempted to assess the increase in urinary creatinine excretion in neonates from a given time. Objectives: To show when urinary creatinine excretion in newborns is efficient. Results: this study mightr show an inflection point in urinary creatinine excretion illustrating the postnatal age when renal function becomes efficient.

CONDITIONS

Official Title

Urinary Creatinine Excretion Time in the Neonatal Period

Who Can Participate

Age: 0 - 3Days
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Full-term newborns (37 weeks of gestation or more)
  • Born from a normal and spontaneous pregnancy
  • Good neonatal adaptation (Apgar score of 7 or more at 5 minutes of life)
  • Normal weight between the 10th and 90th percentile
Not Eligible

You will not qualify if you...

  • Newborns without interpretable urine samples
  • Newborns with significant clinical or biological abnormalities
  • Neonates with hemodynamic disorders such as low blood pressure or signs of dehydration within the first 3 days of life

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Maternite Regionale Universitaire CHRU NANCY

Nancy, Lorraine, France, 54035

Actively Recruiting

Loading map...

Research Team

J

Jean-Michel HASCOET

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

BASIC_SCIENCE

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here